I don't know what will happen with this research
Post# of 148186
this is something like CAR-T but they giving back to patients genetically modified T-cells,
Sound very interesting , lot of side effects could happen.
But IMO it is to soon to talk about it.
I will repeat what Daniel Davis a professor of Immunology at University of Manchester said ..
" At the moment , this is very basic research and not close to actual medicines for patients."